- Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Brief physician advice for problem alcohol
drinkers: long-term efficacy and benefit-cost analysis. A randomized controlled trial in community-based primary care settings.
Alcohol Clin Exp Res. 2002;26:36-43.
- Gentilello LM, Ebel BE, Wickizer TM, Salkever DS, Rivara FP. Alcohol interventions for trauma patients treated in emergency
departments and hospitals: A cost benefit analysis. Ann Surg. 2005;241:541-50.
- U.S. Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am Fam Physician.
2002;65(4):673-76.
- Blandford JM, Gift TL. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory
disease in reproductive-aged women. Sex Transm Dis. In press.
- Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Bin YI, Yi-Ting H. et al. Benefits and costs of using HPV testing to
screen for cervical cancer. JAMA. 2002;287(18):2372-2381.
- Eichler H, Kong SX, Gerth WC, Mavros P, Jönsson B. Use of cost-effectiveness analysis in health-care resource allocation
decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health. 2004;7(5):518-528.
- Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among
American youth, 2000. Perspect Sex Reprod Health. 2004;36(1):11-19.
- Yeh JM, Hook EW, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis.
2003;30(5):369-78.
- Immergluck LC, Cull WL, Schwatrz A, Elstein AS. Cost-effectiveness of universal compared with voluntary screening for human
immunodeficiency virus among pregnant women in Chicago. Pediatrics. 2000;105(4):E54.
- Briss PA, Matte TD, Schwartz J, Rosenblum LS, Binder S. Costs and benefits of a universal screening program for elevated blood
lead levels in 1-year-old children. In: Centers for Disease Control and Prevention. Screening Young Children for Lead Poisoning:
Guidance for State and Local Health Officials. Atlanta, GA: National Center for Environmental Health; 1997.
- Kuiper H, Richwald GA, Rotblatt H, Asch S. The communicable disease impact of eliminating publicly funded prenatal care for
undocumented immigrants. Matern Child Health J. 1999:3(1):39-52.
- Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull World Health Organ. 2004;82(6):402-409.
- Blandford JM, Gift TL. The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. Sex Transm Dis.
2003;30(6):502-8.
- Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost-effectiveness of the clinical practice recommendations in the
AHCPR guideline for smoking cessation. JAMA. 1997:278,1759-1766.
- U.S. Public Health Service. Treating Tobacco use and Dependence: A Systems Approach. Rockville, MD: Office of the U.S. Surgeon
General; U.S. Public Health Service; U.S. Department of Health and Human Services; 2000.
- Maciosek MV, Coffield AB, Edwards NM, Goodman MJ, Flottemesch TJ, Solberg LI. Priorities among effective clinical
preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31(1):52-61.
- Marks JS, Koplan JP, Hogue CJR, et al. A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am J
Prev Med. 1990;6:282-291.
II. Recommended Levels of Care for Physician/Practitioner Services
Not Applicable
III. Emergency Care, Hospitalization, and Other Facility-Based Care
Not Applicable
The Benefits of Prevention and Early Detection
